{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:36:53Z","timestamp":1790177813504,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["22523"],"award-info":[{"award-number":["22523"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00404-020-05825-7","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T23:05:08Z","timestamp":1602025508000},"page":"787-792","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["CYP24A1 expression analysis in uterine leiomyoma regarding MED12 mutation profile"],"prefix":"10.1007","volume":"303","author":[{"given":"Elnaz","family":"Fazeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Piltan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Gholami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojdeh","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Falahati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhrolmolook","family":"Yassaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1709-8975","authenticated-orcid":false,"given":"Reza","family":"Mirfakhraie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"issue":"9252","key":"5825_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","volume":"357","author":"EA Stewart","year":"2001","unstructured":"Stewart EA (2001) Uterine fibroids. The Lancet 357(9252):293\u2013298","journal-title":"The Lancet"},{"issue":"1","key":"5825_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1067\/mob.2003.99","volume":"188","author":"DD Baird","year":"2003","unstructured":"Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188(1):100\u2013107","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"5825_CR3","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1111\/jog.14002","volume":"45","author":"MM Dolmans","year":"2019","unstructured":"Dolmans MM, Donnez J, Fellah L (2019) Uterine fibroid management: today and tomorrow. J Obstet Gynaecol Res 45(7):1222\u20131229. https:\/\/doi.org\/10.1111\/jog.14002","journal-title":"J Obstet Gynaecol Res"},{"key":"5825_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bpobgyn.2017.10.008","volume":"46","author":"J Donnez","year":"2018","unstructured":"Donnez J, Donnez O, Dolmans M-M (2018) The current place of medical therapy in uterine fibroid management. Best Pract Res Clin Obstet Gynaecol 46:57\u201365","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"12","key":"5825_CR5","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/bjc.2016.130","volume":"114","author":"K K\u00e4mpj\u00e4rvi","year":"2016","unstructured":"K\u00e4mpj\u00e4rvi K, M\u00e4kinen N, Mehine M, V\u00e4lipakka S, Uimari O, Pitk\u00e4nen E, Heinonen H-R, Heikkinen T, Tolvanen J, Ahtikoski A (2016) MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas. Br J Cancer 114(12):1405","journal-title":"Br J Cancer"},{"issue":"1","key":"5825_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12943-017-0672-1","volume":"16","author":"N M\u00e4kinen","year":"2017","unstructured":"M\u00e4kinen N, K\u00e4mpj\u00e4rvi K, Frizzell N, B\u00fctzow R, Vahteristo P (2017) Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors. Mol Cancer 16(1):101","journal-title":"Mol Cancer"},{"issue":"5","key":"5825_CR7","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1073\/pnas.1518752113","volume":"113","author":"M Mehine","year":"2016","unstructured":"Mehine M, Kaasinen E, Heinonen H-R, M\u00e4kinen N, K\u00e4mpj\u00e4rvi K, Sarvilinna N, Aavikko M, V\u00e4h\u00e4rautio A, Pasanen A, B\u00fctzow R (2016) Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Proc Natl Acad Sci 113(5):1315\u20131320","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"5825_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.7150\/ijms.21856","volume":"15","author":"M Lee","year":"2018","unstructured":"Lee M, Cheon K, Chae B, Hwang H, Kim H-K, Chung Y-J, Song J-Y, Cho H-H, Kim J-H, Kim M-R (2018) Analysis of MED12 mutation in multiple uterine leiomyomas in South Korean patients. Int J Med Sci 15(2):124","journal-title":"Int J Med Sci"},{"issue":"6053","key":"5825_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1126\/science.1208930","volume":"334","author":"N M\u00e4kinen","year":"2011","unstructured":"M\u00e4kinen N, Mehine M, Tolvanen J, Kaasinen E, Li Y, Lehtonen HJ, Gentile M, Yan J, Enge M, Taipale M (2011) MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 334(6053):252\u2013255","journal-title":"Science"},{"issue":"2","key":"5825_CR10","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s13277-015-3943-8","volume":"37","author":"S Sadeghi","year":"2016","unstructured":"Sadeghi S, Khorrami M, Amin-Beidokhti M, Abbasi M, Kamalian Z, Irani S, Omrani M, Azmoodeh O, Mirfakhraie R (2016) The study of MED12 gene mutations in uterine leiomyomas from Iranian patients. Tumor Biol 37(2):1567\u20131571","journal-title":"Tumor Biol"},{"issue":"3","key":"5825_CR11","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.celrep.2014.03.047","volume":"7","author":"M Turunen","year":"2014","unstructured":"Turunen M, Spaeth JM, Keskitalo S, Park MJ, Kivioja T, Clark AD, M\u00e4kinen N, Gao F, Palin K, Nurkkala H (2014) Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity. Cell Rep 7(3):654\u2013660","journal-title":"Cell Rep"},{"issue":"4","key":"5825_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.fertnstert.2007.01.093","volume":"87","author":"WH Parker","year":"2007","unstructured":"Parker WH (2007) Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 87(4):725\u2013736","journal-title":"Fertil Steril"},{"issue":"3","key":"5825_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/EDE.0b013e31828acca0","volume":"24","author":"DD Baird","year":"2013","unstructured":"Baird DD, Hill MC, Schectman JM, Hollis BW (2013) Vitamin D and risk of uterine fibroids. Epidemiology (Cambridge, Mass) 24(3):447","journal-title":"Epidemiology (Cambridge, Mass)"},{"issue":"5","key":"5825_CR14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc3691","volume":"14","author":"D Feldman","year":"2014","unstructured":"Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ (2014) The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer 14(5):342","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"5825_CR15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1152\/physrev.00014.2015","volume":"96","author":"S Christakos","year":"2015","unstructured":"Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G (2015) Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev 96(1):365\u2013408","journal-title":"Physiol Rev"},{"issue":"2","key":"5825_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jtho.2016.10.010","volume":"12","author":"H Shiratsuchi","year":"2017","unstructured":"Shiratsuchi H, Wang Z, Chen G, Ray P, Lin J, Zhang Z, Zhao L, Beer D, Ray D, Ramnath N (2017) Oncogenic potential of CYP24A1 in lung adenocarcinoma. J Thoracic Oncol 12(2):269\u2013280","journal-title":"J Thoracic Oncol"},{"issue":"1","key":"5825_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3892\/mmr.2016.5992","volume":"15","author":"N Zhalehjoo","year":"2017","unstructured":"Zhalehjoo N, Shakiba Y, Panjehpour M (2017) Gene expression profiles of CYP24A1 and CYP27B1 in malignant and normal breast tissues. Mol Med Rep 15(1):467\u2013473","journal-title":"Mol Med Rep"},{"issue":"2","key":"5825_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00280-005-0059-7","volume":"57","author":"MG Anderson","year":"2006","unstructured":"Anderson MG, Nakane M, Ruan X, Kroeger PE, Wu-Wong JR (2006) Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother Pharmacol 57(2):234\u2013240","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1\u20132","key":"5825_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jsbmb.2010.03.080","volume":"121","author":"H Horvath","year":"2010","unstructured":"Horvath H, Khabir Z, Nittke T, Gruber S, Speer G, Manhardt T, Bonner E, Kallay E (2010) CYP24A1 splice variants\u2014implications for the antitumorigenic actions of 1, 25-(OH) 2D3 in colorectal cancer. J Steroid Biochem Mol Biol 121(1\u20132):76\u201379","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"7","key":"5825_CR20","first-page":"483","volume":"41","author":"KH Kjerulff","year":"1996","unstructured":"Kjerulff KH, Langenberg P, Seidman JD, Stolley PD, Guzinski GM (1996) Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med 41(7):483\u2013490","journal-title":"J Reprod Med"},{"issue":"1","key":"5825_CR21","first-page":"8","volume":"100","author":"ER Myers","year":"2002","unstructured":"Myers ER, Barber MD, Gustilo-Ashby T, Couchman G, Matchar DB, McCrory DC (2002) Management of uterine leiomyomata: What do we really know? Obstet Gynecol 100(1):8\u201317","journal-title":"Obstet Gynecol"},{"issue":"1","key":"5825_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/jbmr.2010","volume":"29","author":"JC Gallagher","year":"2014","unstructured":"Gallagher JC, Jindal PS, Smith LM (2014) Vitamin D supplementation in young White and African American women. J Bone Miner Res 29(1):173\u2013181","journal-title":"J Bone Miner Res"},{"issue":"18","key":"5825_CR23","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.annepidem.2008.08.018","volume":"9","author":"D Baird","year":"2008","unstructured":"Baird D (2008) Hypothesis: vitamin D protects against uterine fibroid development. Ann Epidemiol 9(18):710","journal-title":"Ann Epidemiol"},{"issue":"5","key":"5825_CR24","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/j.fertnstert.2008.02.136","volume":"91","author":"M Bl\u00e4uer","year":"2009","unstructured":"Bl\u00e4uer M, Rovio PH, Ylikomi T, Heinonen PK (2009) Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro. Fertil Steril 91(5):1919\u20131925","journal-title":"Fertil Steril"},{"issue":"1","key":"5825_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.fertnstert.2010.07.1041","volume":"95","author":"C Sharan","year":"2011","unstructured":"Sharan C, Halder SK, Thota C, Jaleel T, Nair S, Al-Hendy A (2011) Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase. Fertil Steril 95(1):247\u2013253","journal-title":"Fertil Steril"},{"issue":"4","key":"5825_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1095\/biolreprod.111.098145","volume":"86","author":"SK Halder","year":"2012","unstructured":"Halder SK, Sharan C, Al-Hendy A (2012) 1, 25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model. Biol Reprod 86(4):116 (111\u2013110)","journal-title":"Biol Reprod"},{"key":"5825_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejogrb.2018.08.018","volume":"229","author":"ER Othman","year":"2018","unstructured":"Othman ER, Ahmed E, Sayed AA, Hussein M, Abdelaal II, Fetih AN, Abou-Taleb HA, Yousef A-EA (2018) Human uterine leiomyoma contains low levels of 1, 25 dihdroxyvitamin D3, and shows dysregulated expression of vitamin D metabolizing enzymes. Eur J Obstet Gynecol Reprod Biol 229:117\u2013122","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"5825_CR28","doi-asserted-by":"publisher","first-page":"E1374","DOI":"10.1210\/jc.2013-1777","volume":"98","author":"A Paffoni","year":"2013","unstructured":"Paffoni A, Somigliana E, Vigano P, Benaglia L, Cardellicchio L, Pagliardini L, Papaleo E, Candiani M, Fedele L (2013) Vitamin D status in women with uterine leiomyomas. J Clin Endocrinol Metab 98(8):E1374\u20131378","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05825-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-020-05825-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05825-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T05:01:14Z","timestamp":1633496474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-020-05825-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["5825"],"URL":"https:\/\/doi.org\/10.1007\/s00404-020-05825-7","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]},"assertion":[{"value":"10 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}